top of page

transforming cancer care
patient-specific innovation
for a billion dollar market

The first and only FDA-cleared patient-specific oral stent scaling oncology precision care

A Chronic Problem: The Critical Unmet Need in Cancer Care

• Over 1 million new cases of oral mucositis annually due to radiation & chemotherapy.

​

• 90%+ of head & neck radiation patients suffer from severe side effects if unprotected.

​

• $40,000 per patient in additional healthcare costs due to complications.

49565_OCS_2024-Number_of_Cancer_Survivors_v01.png

why invest now?

Join Us in Transforming Oncology Care. Sign me up!

Thank you! Your submission has been received. We’ll be in touch soon

Our validated digital workflow makes this commercially viable at scale

ABOUT KALLISIO

At kallisio, we're on a mission to revolutionize head & neck cancer care by safeguarding patients against the harmful effects of radiation therapy. Our 3D printed patient-specific immobilization devices provide unparalleled protection to Organs at Risk (OARs) while allowing radoncs to deliver the highest effective dose of radiation treatment.

SUBSCRIBE

Sign up to receive kallisio news and updates.

Thanks for your interest!

© 2025 Kallisio, Inc. | Privacy Policy

1734 Maryland Ave., Baltimore, MD 21201

  • LinkedIn
bottom of page